Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Inflammatory Bowel Disease Treatment Market: By Drug: Aminosalicylates, Antibiotics, Corticosteroids, Immunomodulators, Biologics, Others; By Disease: Ulcerative Colitis, Crohn’s Disease; By End Use; Regional Analysis; Historical Market and Forecast (2016-2026); Competitive Landscape; Industry Events and Developments

Global Inflammatory Bowel Disease Treatment Market Outlook

The global inflammatory bowel disease treatment market attained a value of about USD 16.7 billion in 2020. The market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 4.5% to reach a value of nearly USD 22 billion by 2026.

 

Global Inflammatory Bowel Disease Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Biosimilars are among the key drivers controlling the market growth as a whole. Biosimilars are anticipated to be less expensive than biotechnological products, which in developing countries make them more accessible. One of the determinants accountable for launching new biologics is the anticipated patent expiry of some of the drugs.

 

Properties and Applications

Inflammatory bowel disease (IBD) is a term used to refer to two diseases (Crohn's disease and ulcerative colitis) characterized by persistent gastrointestinal inflammation (GI) tract. Inflammation for a long period contributes to the damage of the GI tract.

 

Global Inflammatory Bowel Disease Treatment Market By Drug

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on the drug, the inflammatory bowel disease market can be divided into:

  • Aminosalicylates
  • Antibiotics
  • Corticosteroids
  • Immunomodulators
  • Biologics
  • Others

Based on disease, the market is divided into:

  • Ulcerative Colitis
  • Crohn's Disease
  • Indeterminate Colitis

The market can be broadly categorised based on its end-use segments into:

  • Fertility Centres 
  • Hospitals and Surgical Clinics 
  • Research Institutes 
  • Cryobanks

The EMR report looks into the regional markets of inflammatory bowel disease treatment like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Inflammatory Bowel Disease Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The global industry for inflammatory bowel disease treatment is growing globally owing to factors like the rising prevalence of Crohn's disease and ulcerative colitis, increasing government support for research into inflammatory bowel diseases, and the advancements in medical technology. In addition, an increasing number of drugs in clinical trial and the growing popularity of pre-biotic and pro-biotic food products are likely to contribute to the market growth during the evaluation period.

The rise of the market for inflammatory bowel disorders is, however, expected to be limited by the higher costs of capital needed for drug discovery, the inadequate clinical efficacy of therapy, and stringent drug regulatory policies.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global inflammatory bowel disease treatment industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Abbott Laboratories (NYSE: ABT)
  • Biocon Ltd. 
  • F. Hoffmann-La Roche Ag 
  • Johnson & Johnson 
  • Mylan Pharmaceuticals Ltd. 
  • Novartis Ag 
  • Pfizer Inc. 
  • Quest Medical, Inc.
  • Sanofi S.A. 
  • Takeda Pharmaceutical Company Ltd. 

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key findings of the Study
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Inference Data 
3    Executive Summary
    3.1    Market Overview
    3.2    Market Analysis
4    Global Inflammatory Bowel Disease Treatment Market Analysis
    4.1    Global Inflammatory Bowel Disease Treatment Historical Market (2016-2020) & Forecast (2021-2026)
    4.2    Global Inflammatory Bowel Disease Treatment Market Breakup by Drug
        4.2.1    Aminosalicylates
        4.2.2    Antibiotics
        4.2.3    Corticosteroids
        4.2.4    Immunomodulators
        4.2.5    Biologics
        4.2.6    Others
    4.3    Global Inflammatory Bowel Disease Treatment Market Breakup by Drug: Historical Market (2016-2020) & Forecast (2021-2026)
        4.3.1    Aminosalicylates
        4.3.2    Antibiotics
        4.3.3    Corticosteroids
        4.3.4    Immunomodulators
        4.3.5    Biologics
        4.3.6    Others
    4.4    Global Inflammatory Bowel Disease Treatment Market Breakup by Disease
        4.4.1    Ulcerative Colitis
        4.4.2    Crohn’s Disease
        4.4.3    Indeterminate Colitis
    4.5    Global Inflammatory Bowel Disease Treatment Market Breakup by Disease: Historical Market (2016-2020) & Forecast (2021-2026)
        4.5.1    Ulcerative Colitis
        4.5.2    Crohn’s Disease
        4.5.3    Indeterminate Colitis
    4.6    Global Inflammatory Bowel Disease Treatment Market Breakup by End Use
        4.6.1    Fertility Centres
        4.6.2    Hospitals and Surgical Clinics
        4.6.3    Research Institutes
        4.6.4    Cryobanks
    4.7    Global Inflammatory Bowel Disease Treatment Market Breakup by End Use: Historical Market (2016-2020) & Forecast (2021-2026)
        4.7.1    Fertility Centres
        4.7.2    Hospitals and Surgical Clinics
        4.7.3    Research Institutes
        4.7.4    Cryobanks
    4.8    Global Inflammatory Bowel Disease Treatment Market Breakup by Region
        4.8.1    North America 
            4.8.1.1    United States of America
            4.8.1.2    Canada
        4.8.2    Europe 
            4.8.2.1    Germany
            4.8.2.2    United Kingdom
            4.8.2.3    France
            4.8.2.4    Italy
            4.8.2.5    Others
        4.8.3    Asia Pacific
            4.8.3.1    China
            4.8.3.2    Japan
            4.8.3.3    India
            4.8.3.4    ASEAN
            4.8.3.5    Others
        4.8.4    Latin America
            4.8.4.1    Brazil
            4.8.4.2    Argentina
            4.8.4.3    Mexico
            4.8.4.4    Others
        4.8.5    Middle East & Africa 
            4.8.5.1    Saudi Arabia  
            4.8.5.2    United Arab Emirates
            4.8.5.3    Nigeria
            4.8.5.4    South Africa
            4.8.5.5    Others
    4.9     Global Inflammatory Bowel Disease Treatment Market Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
        4.9.1    North America 
            4.9.1.1    United States of America
            4.9.1.2    Canada
        4.9.2    Europe
            4.9.2.1    Germany
            4.9.2.2    United Kingdom
            4.9.2.3    France
            4.9.2.4    Italy
            4.9.2.5    Others
        4.9.3    Asia Pacific
            4.9.3.1    China
            4.9.3.2    Japan
            4.9.3.3    India
            4.9.3.4    ASEAN
            4.9.3.5    Others
        4.9.4    Latin America
            4.9.4.1    Brazil
            4.9.4.2    Argentina
            4.9.4.3    Mexico
            4.9.4.4    Others
        4.9.5    Middle East & Africa 
            4.9.5.1    Saudi Arabia  
            4.9.5.2    United Arab Emirates
            4.9.5.3    Nigeria
            4.9.5.4    South Africa
            4.9.5.5    Others
5    SWOT Analysis
    5.1    Overview
    5.2    Strengths
    5.3    Weaknesses
    5.4    Opportunities
    5.5    Threats
6    Porter’s Five Forces Analysis
    6.1    Overview
    6.2    Buyer’s Power
    6.3    Supplier’s Power
    6.4    New Entrants
    6.5    Degree of Rivalry
    6.6    Substitutes
7    EMR’s Key Indicators for Demand
8    EMR’s Key Indicators for Price

9    Key Players & Company Profiles
    9.1    Abbott Laboratories [ABT (NYSE)]
        9.1.1    Company Overview
        9.1.2    Financial Analysis
    9.2     Biocon Ltd. [BIOCON (NSE)]
        9.2.1    Company Overview
        9.2.2    Financial Analysis
    9.3    F. Hoffmann-La Roche Ag [ROG (SWX)]
        9.3.1    Company Overview
        9.3.2    Financial Analysis
    9.4    Johnson & Johnson [ROG (SWX)]
        9.4.1    Company Overview
        9.4.2    Financial Analysis
    9.5    Mylan Pharmaceuticals Ltd. [MYL (NASDAQ)]
        9.5.1    Company Overview
        9.5.2    Financial Analysis
    9.6    Novartis Ag [ NOVN (SWX)]
        9.6.1    Company Overview
        9.6.2    Financial Analysis
    9.7     Pfizer Inc. [PFE (NYSE)]
        9.7.1    Company Overview
        9.7.2    Financial Analysis
    9.8    Quest Medical, Inc.
        9.8.1    Company Overview
        9.8.2    Financial Analysis
    9.9    Sanofi S.A. [SAN (EPA)]
        9.9.1    Company Overview
        9.9.2    Financial Analysis
    9.10    Takeda Pharmaceutical Company Ltd. [4502 (TYO)]
        9.10.1    Company Overview
        9.10.2    Financial Analysis
10    Industry Events and Developments

Key Questions Answered in the Report

In 2020, the global inflammatory bowel disease treatment market attained a value of nearly USD 16.7 billion.

The market is projected to grow at a CAGR of 4.5% between 2021 and 2026.

The market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach USD 22 billion by 2026.

Major industry drivers include the growing population, rising prevalence of Crohn's disease and ulcerative colitis, increasing government support for research into inflammatory bowel diseases, and the advancements in medical technology.

Key industry trends driving market growth are the growing popularity of pre-biotic and pro-biotic food products and biosimilars, which are anticipated to be less expensive than biotechnological products.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The significant drugs in this industry are amino salicylates, antibiotics, corticosteroids, immunomodulators and biologics, among others.

The major diseases targeted by this market include ulcerative colitis, Crohn's disease and indeterminate colitis.

The leading end use sectors are fertility centres, hospitals and surgical clinics, research institutes, and cryobanks.

The major players in the industry are Abbott Laboratories, Biocon Ltd., F. Hoffmann-La Roche Ag, Johnson & Johnson, Mylan Pharmaceuticals Ltd., Novartis Ag, Pfizer Inc., Quest Medical, Inc., Sanofi S.A., and Takeda Pharmaceutical Company Ltd.

Analyst Review

The global inflammatory bowel disease treatment market attained a value of USD 16.7 billion in 2020, driven by the rising prevalence of Crohn's disease. Aided by the growing popularity of pre-biotic and pro-biotic food products and biosimilars, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 4.5%. The market is projected to reach USD 22 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The drugs in this industry include amino salicylates, antibiotics, corticosteroids, immunomodulators and biologics, among others. The major diseases targeted by this market include ulcerative colitis, Crohn's disease, and indeterminate colitis. The leading end use sectors are fertility centres, hospitals and surgical clinics, research institutes and cryobanks. The major regional markets for inflammatory bowel disease treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Abbott Laboratories, Biocon Ltd., F. Hoffmann-La Roche Ag, Johnson & Johnson, Mylan Pharmaceuticals Ltd., Novartis Ag, Pfizer Inc., Quest Medical, Inc., Sanofi S.A., and Takeda Pharmaceutical Company Ltd.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER